FA
Fred Aslan
DELAYED 1 MONTH
Director, Chief Executive Officer
Artiva Biotherapeutics, Inc.
Filings
1
Companies
1
Latest
May 19, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
70
ARTVCLUSTER 5
Artiva Biotherapeutics, Inc.
Fred Aslan
Director, Chief Executive Officer
Sale
$244.3K
27,116 sh
May 20 1:50 AM
May 19, 2026